Researchers Uncover How Clustered Receptors Amplify Lymphatic Vessel Growth Signals
Korean scientists determined the three-dimensional structure of VEGF-C and VEGFR-3 complexes and discovered that these receptor clusters amplify signaling to control lymphatic vessel development. Understanding this amplification mechanism could lead to new therapeutic strategies for lymphedema, which occurs when lymphatic drainage fails, or for blocking excessive vessel growth that facilitates cancer spread. The research opens pathways to manipulate lymphangiogenic signaling depending on whether vessels need to be enhanced or suppressed.
VEGF-C and VEGFR-3 are signaling molecules and their receptors that play central roles in lymphatic vessel development. Researchers used cryo-EM technology to visualize how these proteins interact in three dimensions, revealing that individual receptor pairs organize into larger clusters along cell membranes. This clustering mechanism acts as a biological amplifier—similar to teams joining forces—that intensifies the strength of growth signals directing lymphatic development.
The practical applications depend on disease context. For lymphedema patients whose lymphatic systems fail to drain properly, enhancing these signals could stimulate vessel formation. Conversely, suppressing cluster formation around tumors might reduce the creation of lymphatic highways that cancer cells exploit for metastasis.
The findings could reshape treatment approaches for two significant health challenges. Lymphedema affects millions globally, often causing chronic disability following cancer surgery or infection. Conversely, cancer metastasis through lymphatic vessels contributes substantially to mortality rates. By identifying the clustering mechanism as a regulatory point, researchers have illuminated a potential intervention target—though clinical translation remains years away, requiring validation that manipulating this pathway proves safe and effective in human patients.